Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 2
1984 1
1986 1
1997 1
2002 2
2003 1
2004 5
2005 4
2007 1
2008 2
2009 3
2010 1
2011 6
2012 7
2013 5
2014 1
2015 5
2016 12
2017 13
2018 8
2019 9
2020 11
2021 9
2022 7
2023 7
2024 11
2025 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study.
Ferrante M, D'Haens G, Jairath V, Danese S, Chen M, Ghosh S, Hisamatsu T, Kierkus J, Siegmund B, Bragg SM, Crandall W, Durand F, Hon E, Lin Z, Lopes MU, Morris N, Protic M, Carlier H, Sands BE; VIVID Study Group. Ferrante M, et al. Lancet. 2024 Dec 14;404(10470):2423-2436. doi: 10.1016/S0140-6736(24)01762-8. Epub 2024 Nov 21. Lancet. 2024. PMID: 39581202 Clinical Trial.
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial.
van der Heijde D, Cheng-Chung Wei J, Dougados M, Mease P, Deodhar A, Maksymowych WP, Van den Bosch F, Sieper J, Tomita T, Landewé R, Zhao F, Krishnan E, Adams DH, Pangallo B, Carlier H; COAST-V study group. van der Heijde D, et al. Lancet. 2018 Dec 8;392(10163):2441-2451. doi: 10.1016/S0140-6736(18)31946-9. Epub 2018 Oct 22. Lancet. 2018. PMID: 30360964 Clinical Trial.
Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial.
Deodhar A, van der Heijde D, Gensler LS, Kim TH, Maksymowych WP, Østergaard M, Poddubnyy D, Marzo-Ortega H, Bessette L, Tomita T, Leung A, Hojnik M, Gallo G, Li X, Adams D, Carlier H, Sieper J; COAST-X Study Group. Deodhar A, et al. Lancet. 2020 Jan 4;395(10217):53-64. doi: 10.1016/S0140-6736(19)32971-X. Epub 2019 Dec 5. Lancet. 2020. PMID: 31813637 Clinical Trial.
Video-Based Interventions for Cancer Control: A Systematic Review.
Blake KD, Thai C, Falisi A, Chou WS, Oh A, Jackson D, Gaysynsky A, Hesse BW. Blake KD, et al. Among authors: thai c. Health Educ Behav. 2020 Apr;47(2):249-257. doi: 10.1177/1090198119887210. Epub 2019 Nov 8. Health Educ Behav. 2020. PMID: 31701780
Barocaloric Effects in Dialkylammonium Halide Salts.
Seo J, Ukani R, Zheng J, Braun JD, Wang S, Chen FE, Kim HK, Zhang S, Thai C, McGillicuddy RD, Yan H, Vlassak JJ, Mason JA. Seo J, et al. Among authors: thai c. J Am Chem Soc. 2024 Jan 31;146(4):2736-2747. doi: 10.1021/jacs.3c12402. Epub 2024 Jan 16. J Am Chem Soc. 2024. PMID: 38227768
Environmental Exposures during Puberty: Window of Breast Cancer Risk and Epigenetic Damage.
Natarajan R, Aljaber D, Au D, Thai C, Sanchez A, Nunez A, Resto C, Chavez T, Jankowska MM, Benmarhnia T, Yang JA, Jones V, Tomsic J, McCune JS, Sistrunk C, Doan S, Serrano M, Cardiff RD, Dietze EC, Seewaldt VL. Natarajan R, et al. Among authors: thai c. Int J Environ Res Public Health. 2020 Jan 13;17(2):493. doi: 10.3390/ijerph17020493. Int J Environ Res Public Health. 2020. PMID: 31941024 Free PMC article. Review.
Admixture into and within sub-Saharan Africa.
Busby GB, Band G, Si Le Q, Jallow M, Bougama E, Mangano VD, Amenga-Etego LN, Enimil A, Apinjoh T, Ndila CM, Manjurano A, Nyirongo V, Doumba O, Rockett KA, Kwiatkowski DP, Spencer CC; Malaria Genomic Epidemiology Network. Busby GB, et al. Elife. 2016 Jun 21;5:e15266. doi: 10.7554/eLife.15266. Elife. 2016. PMID: 27324836 Free PMC article.
130 results